Latest Breaking News On - Activity impairment questionnaire - Page 5 : comparemela.com

Biogen's Tysabri Boosts Cognition Over Long-term in Early RRMS | Multiple Sclerosis News Today

AbbVie to Present Data From its Robust Migraine Portfolio at the Migraine Trust International Symposium 2022

/PRNewswire/ AbbVie (NYSE: ABBV) today announced that new data from its migraine portfolio will be presented at the Migraine Trust International Symposium.

AbbVie to present data from its robust migraine portfolio at the Migraine Trust International Symposium 2022

AbbVie today announced that new data from its migraine portfolio will be presented at the Migraine Trust International Symposium (MTIS) 2022, taking place in London from September 8-11.

Psychological Intervention Looks Promising in Crohn's Disease

A combination of mindfulness and cognitive behavioral therapy showed promise for pain, fatigue, and productivity associated with Crohn s disease.

Lancet Neurology Publishes Positive, Pivotal Phase 3 Data of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive data from the Phase 3 multicenter, placebo-controlled, double-blind,.